1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA C6orf89 CTRPv2 pan-cancer AAC -0.095 0.02
mRNA IFT122 CTRPv2 pan-cancer AAC -0.092 0.02
mRNA INIP CTRPv2 pan-cancer AAC -0.092 0.02
mRNA AC087762.1 CTRPv2 pan-cancer AAC 0.09 0.02
mRNA TRIM39 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA NEURL3 CTRPv2 pan-cancer AAC 0.093 0.02
mRNA USP30 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA KLHDC4 CTRPv2 pan-cancer AAC -0.099 0.02
mRNA TRAF3IP2 CTRPv2 pan-cancer AAC 0.095 0.02
mRNA AC002310.13 CTRPv2 pan-cancer AAC -0.093 0.02
Download CSV